Moreover, the knockdown of HULC inhibits proliferation, migration, and invasion and promotes apoptosis in osteosarcoma.(Wang et al. 2017a; Li et al. 2017; Kong and Wang 2018) All the data suggest that HULC has the potential to be a diagnostic marker or therapeutic target for osteosarcoma. This evidence concerns the gene HULC and osteosarcoma.